Pinnacle begins Phase III bile duct cancer trial of PHOTOFRIN
The trial is being conducted in Germany for a rare form of bile duct cancer for which currently there is no acceptable therapy. About 200 patients will be
Voro Therapeutics and Alloy Therapeutics have formed a strategic research partnership to develop tumour-selective, next-generation masked T-cell engager (TCE) therapeutics.
NurOwn includes autologous mesenchymal stem cells that have been induced to secrete neurotrophic factors. The company is currently, evaluating NurOwn in a randomized, double-blind, placebo-controlled Phase II clinical
As patients find that they are unable to refill their hydrocodone prescription, this paper presents alternatives that should be discussed with their physician. The release of the white